Ona Therapeutics is a biotechnology company intended to discover and develop therapeutic biologics targeting tumor metastatic-initiating cells and lipid metabolism. Its therapeutic biologics inhibits the cells that give rise to metastases, with the potential to not only prevent the development of these malignant growths but also to eliminate existing ones. The company aims to enable healthcare institutes to treat various metastatic tumors, such as oral, breast, ovarian, gastric, bladder, prostate, and melanoma.